Close Menu

NEW YORK (GenomeWeb) – OpGen reported after the close of the market Tuesday that its fourth quarter revenues fell 23 percent year over year.

For the three months ended Dec. 31, 2018, OpGen logged $758,959 in revenues compared to $990,912 in the year-ago quarter.

Fourth quarter product sales fell 6 percent to $589,749 from $626,498; laboratory services revenue ticked up 34 percent to $12,510 from $935; and collaboration revenue dropped 57 percent to $156,700 from $363,479.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.